These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8082292)
21. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients. Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL Thymus; 1997; 24(3):147-56. PubMed ID: 9151380 [TBL] [Abstract][Full Text] [Related]
22. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy. Johnson BJ; Ress SR; Willcox P; Pati BP; Lorgat F; Stead P; Saha R; Lukey P; Laochumroonvorapong P; Corral L Cytokines Mol Ther; 1995 Sep; 1(3):185-96. PubMed ID: 9384675 [TBL] [Abstract][Full Text] [Related]
23. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. Elmi OS; Hasan H; Abdullah S; Mat Jeab MZ; Bin Alwi Z; Naing NN J Infect Dev Ctries; 2015 Oct; 9(10):1076-85. PubMed ID: 26517482 [TBL] [Abstract][Full Text] [Related]
24. NK cell activity in pulmonary tuberculosis. Yoneda T; Kasai M; Ishibashi J; Nishikawa K; Tokunaga T; Mikami R Br J Dis Chest; 1983 Apr; 77(2):185-8. PubMed ID: 6871086 [TBL] [Abstract][Full Text] [Related]
25. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D. Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231 [TBL] [Abstract][Full Text] [Related]
27. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil. de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203 [TBL] [Abstract][Full Text] [Related]
28. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis. Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512 [TBL] [Abstract][Full Text] [Related]
29. Aberrant Toll-like receptor 2 promoter methylation in blood cells from patients with pulmonary tuberculosis. Chen YC; Hsiao CC; Chen CJ; Chao TY; Leung SY; Liu SF; Wang CC; Wang TY; Chang JC; Wu CC; Lin AS; Wang YH; Lin MC J Infect; 2014 Dec; 69(6):546-57. PubMed ID: 25218055 [TBL] [Abstract][Full Text] [Related]
30. Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis. Ramana Rao PV; Rajasekaran S; Raja A J Interferon Cytokine Res; 2010 Jan; 30(1):33-42. PubMed ID: 20028198 [TBL] [Abstract][Full Text] [Related]
31. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387 [TBL] [Abstract][Full Text] [Related]
32. Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis. Sharma S; Sharma M; Roy S; Kumar P; Bose M Immunol Cell Biol; 2004 Aug; 82(4):377-82. PubMed ID: 15283847 [TBL] [Abstract][Full Text] [Related]
33. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns. Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562 [TBL] [Abstract][Full Text] [Related]
34. Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects. Lima JF; Oliveira LMS; Pereira NZ; Duarte AJS; Sato MN Sci Rep; 2017 Apr; 7(1):524. PubMed ID: 28373665 [TBL] [Abstract][Full Text] [Related]
35. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes. Flexman JP; Manning LS; Robinson BW Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789 [TBL] [Abstract][Full Text] [Related]